Incidental Mutation 'IGL03226:Tnfsf10'
ID 414853
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Tnfsf10
Ensembl Gene ENSMUSG00000039304
Gene Name tumor necrosis factor (ligand) superfamily, member 10
Synonyms APO-2L, A330042I21Rik, Trail
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # IGL03226
Quality Score
Status
Chromosome 3
Chromosomal Location 27371226-27393814 bp(+) (GRCm39)
Type of Mutation nonsense
DNA Base Change (assembly) C to A at 27389597 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Tyrosine to Stop codon at position 219 (Y219*)
Ref Sequence ENSEMBL: ENSMUSP00000040271 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000046383] [ENSMUST00000174840]
AlphaFold P50592
Predicted Effect probably null
Transcript: ENSMUST00000046383
AA Change: Y219*
SMART Domains Protein: ENSMUSP00000040271
Gene: ENSMUSG00000039304
AA Change: Y219*

DomainStartEndE-ValueType
transmembrane domain 20 42 N/A INTRINSIC
TNF 146 290 5.35e-37 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000174840
SMART Domains Protein: ENSMUSP00000133917
Gene: ENSMUSG00000039304

DomainStartEndE-ValueType
transmembrane domain 15 37 N/A INTRINSIC
Pfam:TNF 156 226 7.1e-17 PFAM
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
PHENOTYPE: Homozygotes for a null allele show thymus hyperplasia, abnormal negative T cell selection, increased susceptibility to autoimmune diseases and to tumor initiation and metastasis, and resistance to induced hepatitis. Homozygotes for another null allele are unable to control A20 lymphoma progression. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 34 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
9930012K11Rik A G 14: 70,395,058 (GRCm39) V32A probably damaging Het
Als2 T C 1: 59,225,679 (GRCm39) T944A probably benign Het
Bcat2 T A 7: 45,237,778 (GRCm39) V348E probably damaging Het
Bnip2 A G 9: 69,903,456 (GRCm39) D36G probably benign Het
C2cd5 T A 6: 143,018,292 (GRCm39) D310V possibly damaging Het
Cltc G A 11: 86,611,113 (GRCm39) T582M probably damaging Het
Cplx3 A T 9: 57,517,290 (GRCm39) Y365N probably benign Het
Dync2h1 T C 9: 7,125,918 (GRCm39) H1896R probably benign Het
Efcab5 T C 11: 77,028,501 (GRCm39) R413G possibly damaging Het
Fam131b C T 6: 42,295,888 (GRCm39) M169I possibly damaging Het
Fam241b A G 10: 61,945,671 (GRCm39) S52P probably benign Het
Gpd2 G A 2: 57,194,498 (GRCm39) probably null Het
Gucy1a1 T A 3: 82,026,331 (GRCm39) Q41L probably benign Het
Ifna16 T C 4: 88,594,741 (GRCm39) D118G probably benign Het
Kcnn1 T C 8: 71,299,135 (GRCm39) probably benign Het
Lyl1 C T 8: 85,429,300 (GRCm39) P3L possibly damaging Het
Lyst A T 13: 13,884,144 (GRCm39) H2984L probably benign Het
Myh7b C T 2: 155,462,403 (GRCm39) Q369* probably null Het
Nalcn A C 14: 123,518,527 (GRCm39) W1671G probably benign Het
Ndrg2 G A 14: 52,144,026 (GRCm39) probably benign Het
Nfia C A 4: 97,951,286 (GRCm39) P371Q probably damaging Het
Or10d5 A C 9: 39,861,719 (GRCm39) probably null Het
Pcdhb22 A G 18: 37,652,009 (GRCm39) D159G probably damaging Het
Plekhm3 A T 1: 64,960,959 (GRCm39) D432E possibly damaging Het
Pramel17 T A 4: 101,692,594 (GRCm39) T469S probably benign Het
Rab2a A G 4: 8,606,448 (GRCm39) N195S probably benign Het
Sbf1 A G 15: 89,173,308 (GRCm39) Y1764H possibly damaging Het
Scap A G 9: 110,213,335 (GRCm39) T1127A possibly damaging Het
Shld2 T C 14: 33,990,328 (GRCm39) T193A probably benign Het
Slc45a2 A G 15: 11,022,278 (GRCm39) D340G probably damaging Het
Tbc1d23 A T 16: 57,034,625 (GRCm39) L58Q probably damaging Het
Tmcc1 T C 6: 116,110,937 (GRCm39) T119A probably damaging Het
Traip G A 9: 107,848,192 (GRCm39) R437Q probably damaging Het
Tyw3 T C 3: 154,293,187 (GRCm39) T163A possibly damaging Het
Other mutations in Tnfsf10
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02155:Tnfsf10 APN 3 27,389,380 (GRCm39) missense possibly damaging 0.71
IGL03071:Tnfsf10 APN 3 27,389,769 (GRCm39) missense probably damaging 1.00
IGL03157:Tnfsf10 APN 3 27,380,106 (GRCm39) missense possibly damaging 0.77
R4051:Tnfsf10 UTSW 3 27,389,503 (GRCm39) missense probably damaging 1.00
R4679:Tnfsf10 UTSW 3 27,389,728 (GRCm39) missense probably damaging 0.99
R5799:Tnfsf10 UTSW 3 27,389,742 (GRCm39) missense probably damaging 1.00
R6101:Tnfsf10 UTSW 3 27,389,698 (GRCm39) missense probably damaging 1.00
R6105:Tnfsf10 UTSW 3 27,389,698 (GRCm39) missense probably damaging 1.00
R6882:Tnfsf10 UTSW 3 27,380,182 (GRCm39) missense possibly damaging 0.95
R7362:Tnfsf10 UTSW 3 27,389,497 (GRCm39) missense probably damaging 1.00
R7873:Tnfsf10 UTSW 3 27,389,808 (GRCm39) missense probably benign 0.05
R8819:Tnfsf10 UTSW 3 27,389,451 (GRCm39) missense probably benign 0.07
R9034:Tnfsf10 UTSW 3 27,389,379 (GRCm39) missense probably benign 0.00
R9035:Tnfsf10 UTSW 3 27,389,379 (GRCm39) missense probably benign 0.00
R9125:Tnfsf10 UTSW 3 27,380,028 (GRCm39) intron probably benign
R9193:Tnfsf10 UTSW 3 27,371,407 (GRCm39) missense possibly damaging 0.90
R9334:Tnfsf10 UTSW 3 27,389,496 (GRCm39) missense probably damaging 1.00
Posted On 2016-08-02